p.4 抽出テキスト
Tables of Recommendations Recommendation Table 1 — Recommendations for the diagnosis of AF (see also Evidence Table 1) ....................................................................... 3328 Recommendation Table 2 — Recommendations for symptom evaluation in patients with AF (see also Evidence Table 2) ................ 3328 Recommendation Table 3 — Recommendations for diagnostic evaluation in patients with new AF (see also Evidence Table 3) ..... 3328 Recommendation Table 4 — Recommendations for patient-centred care and education (see also Evidence Table 4) ...................................... 3332 Recommendation Table 5 — Recommendations for comorbidity and risk factor management in AF (see also Evidence Table 5) ....... 3339 Recommendation Table 6 — Recommendations to assess and manage thromboembolic risk in AF (see also Evidence Table 6) .... 3342 Recommendation Table 7 — Recommendations for oral anticoagulation in AF (see also Evidence Table 7) .................................. 3344 Recommendation Table 8 — Recommendations for combining antiplatelet drugs with anticoagulants for stroke prevention (see also Evidence Table 8) .................................................................................................. 3346 Recommendation Table 9 — Recommendations for thromboembolism despite anticoagulation (see also Evidence Table 9) ..................................................................................................................... 3346 Recommendation Table 10 — Recommendations for percutaneous left atrial appendage occlusion (see also Evidence Table 10) ............ 3347 Recommendation Table 11 — Recommendations for surgical left atrial appendage occlusion (see also Evidence Table 11) .................... 3348 Recommendation Table 12 — Recommendations for assessment of bleeding risk (see also Evidence Table 12) ................................................. 3348 Recommendation Table 13 — Recommendations for management of bleeding in anticoagulated patients (see also Evidence Table 13) 3351 Recommendation Table 14 — Recommendations for heart rate control in patients with AF (see also Evidence Table 14) ................... 3351 Recommendation Table 15 — Recommendations for general concepts in rhythm control (see also Evidence Table 15) .................. 3355 Recommendation Table 16 — Recommendations for electrical cardioversion of AF (see also Evidence Table 16) .................................. 3356 Recommendation Table 17 — Recommendations for pharmacological cardioversion of AF (see also Evidence Table 17) 3356 Recommendation Table 18 — Recommendations for antiarrhythmic drugs for long-term maintenance of sinus rhythm (see also Evidence Table 18) ............................................................................ 3358 Recommendation Table 19 — Recommendations for catheter ablation of AF (see also Evidence Table 19) ............................................. 3359 Recommendation Table 20 — Recommendations for anticoagulation in patients undergoing catheter ablation (see also Evidence Table 20) ............................................................................................... 3360 Recommendation Table 21 — Recommendations for endoscopic and hybrid AF ablation (see also Evidence Table 21) ........................... 3360 Recommendation Table 22 — Recommendations for AF ablation during cardiac surgery (see also Evidence Table 22) ............................. 3361 Recommendation Table 23 — Recommendations to improve patient experience (see also Evidence Table 23) .................................... 3364 Recommendation Table 24 — Recommendations for patients with acute coronary syndromes or undergoing percutaneous intervention (see also Evidence Table 24) ................................................. 3366 Recommendation Table 25 — Recommendations for trigger-induced AF (see also Evidence Table 25) .................................... 3368 Recommendation Table 26 — Recommendations for management of post-operative AF (see also Evidence Table 26) ............................... 3368 Recommendation Table 27 — Recommendations for patients with embolic stroke of unknown source (see also Evidence Table 27) .. 3369 Recommendation Table 28 — Recommendations for patients with AF during pregnancy (see also Evidence Table 28) ................................ 3369 Recommendation Table 29 — Recommendations for patients with AF and congenital heart disease (see also Evidence Table 29) ......... 3370 Recommendation Table 30 — Recommendations for prevention of thromboembolism in atrial flutter (see also Evidence Table 30) ..... 3371 Recommendation Table 31 — Recommendations for screening for AF (see also Evidence Table 31) .................................................................... 3374 Recommendation Table 32 — Recommendations for primary prevention of AF (see also Evidence Table 32) ....................................... 3376 List of tables Table 1 Classes of recommendations .......................................................... 3320 Table 2 Levels of evidence ................................................................................ 3320 Table 3 New recommendations .................................................................... 3322 Table 4 Revised recommendations ............................................................... 3325 Table 5 Definitions and classifications for the temporal pattern of AF ................................................................................................................................. 3327 Table 6 Other clinical concepts relevant to AF ....................................... 3327 Table 7 The modified European Heart Rhythm Association (mEHRA) symptom classification ................................................................... 3329 Table 8 Diagnostic work-up for patients with AF .................................. 3330 Table 9 Achieving patient-centred AF management ............................. 3331 Table 10 Updated definitions for the CHA2DS2-VA score ............... 3342 Table 11 Recommended doses for direct oral anticoagulant therapy ....................................................................................................................... 3345 Table 12 Drugs for rate control in AF ........................................................ 3352 Table 13 Antiarrhythmic drugs for sinus rhythm restoration ........... 3357 Table 14 Non-cardiac conditions associated with trigger-induced AF ................................................................................................................................. 3367 Table 15 Tools for AF screening .................................................................... 3373 Table 16 Factors associated with incident AF .......................................... 3375 Table 17 ‘What to do’ and ‘what not to do’ ............................................ 3379 List of figures Figure 1 Impacts and outcomes associated with clinical AF. AF, atrial fibrillation .................................................................................................................. 3329 Figure 2 Multidisciplinary approach to AF management ...................... 3331 Figure 3 Central illustration. Patient pathway for AF-CARE (see Figures 4, 5, 6, and 7 for the [R] pathways for first-diagnosed, paroxysmal, persistent and permanent AF) ................................................................................ 3333 Figure 4 [R] Pathway for patients with first-diagnosed AF ................. 3334 Figure 5 [R] Pathway for patients with paroxysmal AF ....................... 3335 Figure 6 [R] Pathway for patients with persistent AF .......................... 3336 Figure 7 [R] Pathway for patients with permanent AF ........................ 3337 Figure 8 Management of key comorbidities to reduce AF recurrence ................................................................................................................ 3338 Figure 9 Common drug interactions with oral anticoagulants .......... 3343 Figure 10 Modifying the risk of bleeding associated with OAC ....... 3349 Figure 11 Management of oral anticoagulant-related bleeding in patients with AF .................................................................................................... 3350 Figure 12 Approaches for cardioversion in patients with AF ............ 3354 Figure 13 Relevance of echocardiography in the AF-CARE pathway 3363 Figure 14 Antithrombotic therapy in patients with AF and acute or chronic coronary syndromes ........................................................................... 3365 ESC Guidelines 3317 Downloaded from academic.oup.com/eurheartj/article/45/36/3314/7738779 by guest on 07 October 2026